Dopamine and cognitive function

Current Opinion in Neurology

Volumn 16, Issue SUPPL. 2, 2003, Pages

  Pillon, Bernard ^a   Czernecki, Virginie ^a   Dubois, Bruno ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cognitive deficits; Deep brain stimulation; Idiopathic Parkinson's disease; Levo dihydroxyphenylalanine; Neurobiological basis; Personality disorders

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; LEVODOPA;

APATHY; BRAIN CORTEX LESION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DELUSION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DYSKINESIA; DYSPRAXIA; EUPHORIA; HALLUCINATION; HUMAN; LEARNING DISORDER; MEMORY DISORDER; MENTAL DISEASE; MOTOR DYSFUNCTION; NEUROPATHOLOGY; NEUROPSYCHOLOGY; PALLIDOTOMY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERSONALITY DISORDER; REVIEW; SURGICAL TECHNIQUE; WORKING MEMORY;

EID: 1342301453     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200312002-00004     Document Type: Review

References (43)

1. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997; 244:2-8.
2. Crucian GP, Barrett AM, Schwartz RL, et al. Cognitive and vestibulo-proprioceptive components of spatial ability in Parkinson's disease. Neuropsychologia 2000; 38:757-767.
3. Pillon B, Deweer B, Vidailhet M, et al. Is impaired memory for spatial location in Parkinson's disease domain specific or dependent on 'strategic' processes? Neuropsychologia 1998; 36:1-9.
4. Dujardin K, Defebvre J, Grunberg C, et al. Memory and executive function in sporadic and familial Parkinson's disease. Brain 2001; 124:389-398.
5. Partiot A, Vérin M, Pillon B, et al. Delayed response task in basal ganglia lesions in man. Further evidence for a striato-frontal cooperation in behavioral adaptation. Neuropsychologia 1996; 34:709-721.
6. Bruck A, Portin R, Lindell A, et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 2001; 311:81-84.
7. Mattay VS, Tessitore A, Callicot JH, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 2002; 51:156-164.
8. Fournet N, Moreaud O, Roulin JL, et al. Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication. Neuropsychology 2000; 14:247-253.
9. Duchesne N, Soucy JP, Masson H, et al. Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa. Clin Neuropharmacol 2002; 25:216-224.
10. Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001; 11:1136-1143.
11. Grossman M, Lee C, Morris J, et al. Assessing resource demands during sentence processing in Parkinson's disease. Brain Lang 2002; 80:603-616.
12. Cools R, Stefanova E, Barker RA, et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 2002; 125:584-594.
13. Malapani C, Deweer B, Gibbon J. Separating storage from retrieval dysfunction of temporal memory in Parkinson's disease. J Cogn Neurosci 2002; 14:311-322.
14. Czernecki V, Pillon B, Houeto JL, et al. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002; 40:2257-2267.
15. Schubert T, Volkmann J, Muller U, et al. Effects of pallidal deep brain stimulation and levodopa treatment on reaction-time performance in Parkinson's disease. Exp Brain Res 2002; 144:8-16.
16. Press DZ, Mechanic DJ, Tassy D, Manoach DS. Cognitive slowing in Parkinson's disease resolves after practice. J Neurol Neurosurg Psychiatry 2002; 73:524-528.
17. Witjas T, Kaphan E, Azulay JP, et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002; 59:408-413.
18. Trepanier LL, Kumar R, Lozano AM, et al. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn 2000; 42:324-347.
19. Lombardi WJ, Gross RE, Trepanier LL, et al. Relationship of lesion location to cognitive outcome following microelectrode-guided pallidotomy for Parkinson's disease: support for the existence of cognitive circuits in the human pallidum. Brain 2000; 123:746-758.
20. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46:217-223.
21. Daniele A, Albanese A, Contarino MF, et al. Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74:175-182.
22. Brusa L, Pierantozzi M, Peppe A, et al. Deep brain stimulation (DBS) attentional effects parallel those of L-DOPA treatment. J Neurol Transm 2001; 108:1021-1027.
23. Pillon B, Ardouin C, Damier P, et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 2000; 55:411-418.
24. Jahanshahi M, Ardouin C, Brown R, et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 2000; 123:1142-1154.
25. Funkiewiez A, Ardouin C, Krack P, et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord 2003; 18:524-530.
26. Pillon B, Czernecki V, Houeto JL, et al. Does deep brain stimulation of the STN influence apathy and reward sensitivity in PD patients? In: 55th Annual Meeting of the American Academy of Neurology. Honolulu, Hawaii, 29 March-5 April 2003 [Abstract P03.051].
27. Schroeder U, Kuehler A, Haslinger B, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002; 125:1995-2004.
28. Jacobs H, Heberlein I, Vieregge A, et al. Personality traits in young patients with Parkinson's disease. Acta Neurol Scand 2001; 103:82-87.
29. Slaughter JR, Slaughter KA, Nichols D, et al. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13:187-196.
30. Aarsland D, Ballard C, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 2001; 16:528-536.
31. McKeith I, Del Ser T, Spano PF, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double blind, placebo-controlled international study. Lancet 2000; 356:2031-2036.
32. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314.
33. Robert PH, Clairet S, Benoit M, et al. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry 2002; 17:1099-1105.
34. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73:636-642.
35. Saint-Cyr J, Trepanier L, Kumar R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123:2091-2108.
36. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72:701-717.
37. Cools R, Barker RA, Sahakian BJ, Robbins TW. L-DOPA medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003; 41:1431-1441.
38. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55:1621-1626.
39. Barber R, Panikkar A, McKeith IG. Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry 2001; 16 (Suppl. 1):12-18.
40. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002; 59:1714-1720.
41. Mattila PM, Roytta M, Lonnberg P, et al. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathol 2001; 102:160-166.
42. Apaydin H, Ahlskog JE, Parisi JE, et al. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002; 59:102-112.
43. Ouchi Y, Yoshikawa E, Okada H, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for β-CFT binding with positron emission tomography. Ann Neurol 1999; 45:601-610.